Bumetanide As a Candidate Treatment for Behavioral Problems in Tuberous Sclerosis Complex

BACKGROUND: Recent studies indicate excitatory GABA action in and around tubers in patients with tuberous sclerosis complex (TSC). This may contribute to recurrent seizures and behavioral problems that may be treated by agents that enhance GABAergic transmission by influencing chloride regulation. C...

Descripción completa

Detalles Bibliográficos
Autores principales: Vlaskamp, Chantal, Poil, Simon-Shlomo, Jansen, Floor, Linkenkaer-Hansen, Klaus, Durston, Sarah, Oranje, Bob, Bruining, Hilgo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596068/
https://www.ncbi.nlm.nih.gov/pubmed/28943860
http://dx.doi.org/10.3389/fneur.2017.00469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596068/
https://www.ncbi.nlm.nih.gov/pubmed/28943860
http://dx.doi.org/10.3389/fneur.2017.00469

Ejemplares similares